Table 1.
Demographic and clinical data of the studied groups
| Parameter | HCC (n = 24) | LC (n = 24) | Control (n = 24) | p* |
|---|---|---|---|---|
| Age (years) | 56.4 ±7.9 | 55.5 ±6.5 | 54.4 ±5.3 | 0.122 |
| Male sex, n (%) | 15 (62.5) | 14 (58.33) | 15 (62.5) | 0.104 |
| Child score | 10.9 ±1.9 | 10.0 ±2.7 | – | 0.092 |
| Child class, n (%) | ||||
| A | 0 (0) | 0 (0) | – | 0.211 |
| B | 9 (37.5) | 11 (45.8) | – | |
| C | 15 (62.5) | 13 (54.2) | – | |
| BCLC stage of HCC, n (%) | ||||
| Very early | 4 (16.7) | – | – | – |
| Early | 4 (16.7) | – | – | – |
| Intermediate | 1 (4.2) | – | – | – |
| Advanced | 15 (62.5) | – | – | – |
HCC – hepatocellular carcinoma, LC – liver cirrhosis, BCLC – Barcelona Clinic Liver Cancer, n – number
*
statistically significant at p < 0.05